2010 Innovators
The Innovator Presentation track featured 31 novel research approaches that can move a field of research forward. Each 25-minute presentation was a tangible case study on an innovative, cross-sector approach to medical research, development, funding and/or partnering.
- Accelerated Cure Project Biorepository
Presented by: Hollie Schmidt, Vice President of Scientific Operations, Accelerated Cure Project for Multiple Sclerosis
2:30 pm – 2:55 pm
Room: Alvin
- The Accelerator of Cancer Treatments in Children
Presented by: Beth Anne Baber, Ph.D., M.B.A., Co-Founder and CEO, The Nicholas Conor Institute for Pediatric Cancer Research
10:45 am – 11:10 am
Room: Uris
- BioPontis Alliance
Presented by: Barbara Handelin, President, BioPontis Alliance, LLC
4:00 pm – 4:25 pm
Room: Broadway
- Cancer Commons
Presented by: Jay M. Tenenbaum, Chairman, CEO and Chief Scientist, CollabRx
11:00 am – 11:25 am
Room: Broadway
- Cancer E-Life Collaboration
Presented by: Ken Buetow, Ph.D., Associate Director, Bioinformatics and Information Technology, National Cancer Institute and Jon Handler M.D., Chief Architect, Microsoft Health Solutions Group
10:30 am – 10:55 am
Room: Broadway
- Centre for Drug Research and Development
Presented by: Natalie Dakers, President and CEO, Centre for Drug Research and Development
10:15 am – 10:40 am
Room: Broadway
- Cerebrospinal Fluid Quality Control Initiative
Presented by: Maria Carrillo, Ph.D., Senior Director, Medical and Scientific Relations, Alzheimer's Association
11:00 am – 11:25 am
Room: Alvin
- Clinical Trial Comparator Arm Partnership
Presented by: Sharon Terry, M.A., President and CEO, Genetic Alliance; Stephen Friend, M.D., Ph.D., President, Sage Bionetworks
11:15 am – 11:40 am
Room: Broadway
- DART Therapeutics
Presented by: Eugene Williams, Chairman, DART Therapeutics, LLC
3:30 pm – 3:55 pm
Room: Broadway
- Discontinued Clinical Compound Library: Academic Drug Repositioning
Presented by: Kate Marusina, Ph.D., Manager, Industry Alliances, Clinical and Translational Sciences Center, University of California, Davis
4:00 pm – 4:25 pm
Room: Alvin
- Enabling Molecularly Informed Cancer Medicine, National Cancer Institute
Presented by: Richard Aragon, Ph.D., Director, IMAT Program, National Cancer Institute, and Anthony Dickherber, Ph.D., Office of the Director, National Cancer Institute
3:30 pm – 3:55 pm
Room: Alvin
- The Epilepsy Study Consortium
Presented by: Jacqueline A. French, M.D., President, and Joyce A. Cramer, President, Epilepsy Therapy
4:00 pm – 4:25 pm
Room: Regency
- findAKUre
Presented by: Dr. Nicolas Sireau, Chairman, AKU Society, United Kingdom, and Dr. Lakshminarayan Ranganath, Consultant Chemical Pathologist and Honorary Senior Lecturer, Royal Liverpool University Hospital, United Kingdom
3:30 pm – 3:55 pm
Room: Regency
- Global Health Portfolio, Foundation for the NIH
Presented by: Scott E. Campbell, Ph.D., Executive Director and CEO, Foundation for the National Institutes of Health
10:45 am – 11:10 am
Room: Alvin
- Health Impact Fund Pilot, Incentives for Global Health
Presented by: Harvey Rubin, Professor of Medicine, University of Pennsylvania, and Chair of the Scientific Advisory Committee, Incentives for Global Health
3:00 pm – 3:25 pm
Room: Regency
- Health of Women Study
Presented by: Naz Sykes, Executive Director, Dr. Susan Love Research Foundation
10:15 am – 10:40 am
Room: Alvin
- Hospital Medicine Reengineering Network
Presented by: Aaron Abend, Managing Director–Data Warehousing, Recombinant Data Corporation 10:45 am – 11:10 am
Room: Broadway
- International AIDS Vaccine Initiative, Innovation Fund
Presented by: Seth Berkley, M.D., President and CEO, International AIDS Vaccine Initiative
4:00 pm – 4:25 pm
Room: Uris
- International Partnership for Microbicides
Presented by: Pamela M. Norick, Chief of External Relations, and Michael E. Green, Executive Director of Resource Development, International Partnership for Microbicides
2:30 pm – 2:55 pm
Room: Regency
- Ivy Genomics Based Medicine Project
Presented by: Michael E. Berens, Ph.D., Director and Senior Investigator, Translational Genomics Research Institute
3:30 pm – 3:55 pm
Room: Uris
- LaunchPad Fund, Biomedical Innovation in Diabetes
Presented by: Greg Fralish, Program Director, Translational Research, and Mark Crowell, Executive Director and Associate Vice President, Innovation Partnerships and Commercialization, University of Virginia
2:30 pm – 2:55 pm
Room: Broadway
- Melanoma Research Alliance Academic-Industrial Partnership Awards
Presented by: Suzanne L. Topalian, M.D., Chief Science Officer, and Laura Brockway-Lunardi, Ph.D., Scientific Program Director, Melanoma Research Alliance
3:00 pm – 3:25 pm
Room: Uris
- Multiple Myeloma Research Foundation, Personalized Medicine Initiative
Presented by: Kathy Giusti, Founder and CEO, Multiple Myeloma Research Foundation, and Gerald McDougall, Partner, PricewaterhouseCoopers, MMRF and MMRC Board Member
10:30 am – 10:55 am
Room: Alvin
- Neurofibromatosis Preclinical Consortium
Presented by: Kim Hunter-Schaedle, Ph.D., Chief Scientific Officer, Children's Tumor Foundation
11:15 am – 11:40 am
Room: Uris
- OncoNet
Presented by: Eliav Barr, Vice President, Oncology Clinical Research, Merck Research Laboratories
3:00 pm – 3:25 pm
Room: Alvin
- Parkinson's Progression Markers Initiative
Presented by: Sohini Chowdhury, Vice President, Research Partnerships, Michael J. Fox Foundation for Parkinson's Research
11:15 am – 11:40 am
- Product Development Partnership for a Malaria Vaccine: PATH Malaria Vaccine Initiative, GlaxoSmithKline Biologicals
Presented by: Christian Loucq, M.D., Director, PATH Malaria Vaccine Initiative
10:30 am – 10:55 am
Room: Uris
- Seaside Therapeutics, Merck, NIH, FRAXA, and Autism Speaks
Presented by: Randall L. Carpenter, M.D., President and CEO, Seaside Therapeutics, and Linda Brady, Ph.D., Director, Division of Neuroscience & Basic Behavioral Science, National Institute of Mental Health
2:30 pm – 2:55 pm
Room: Uris - Tolerx-Cancer Research Institute Acceleration Fund
Presented by: Christopher Merrill, Director, Business Development, Tolerx, Inc., and Adam Kolom, Director, Cancer Vaccine Acceleration Fund, Cancer Research Institute
11:00 am – 11:25 am
Room: Uris